| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
122,748 |
97,422 |
$6.02M |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
48,174 |
35,869 |
$1.47M |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
11,963 |
9,593 |
$1.29M |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
9,516 |
7,240 |
$420K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
4,752 |
3,572 |
$288K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,236 |
8,172 |
$212K |
| 99443 |
|
10,933 |
9,143 |
$174K |
| 64635 |
|
1,628 |
1,148 |
$156K |
| 99406 |
|
15,372 |
12,718 |
$115K |
| 64483 |
|
1,616 |
1,307 |
$114K |
| 64493 |
|
1,287 |
844 |
$86K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
8,124 |
6,587 |
$82K |
| 64636 |
|
1,679 |
990 |
$78K |
| 99442 |
|
4,464 |
3,677 |
$75K |
| 81025 |
|
13,697 |
11,328 |
$70K |
| 27096 |
|
1,173 |
983 |
$61K |
| 64633 |
|
600 |
432 |
$59K |
| 64490 |
|
698 |
478 |
$52K |
| 64494 |
|
1,408 |
708 |
$46K |
| 62321 |
|
593 |
493 |
$40K |
| 84443 |
Thyroid stimulating hormone (TSH) |
7,526 |
6,108 |
$38K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
3,174 |
2,374 |
$35K |
| 77002 |
|
1,511 |
1,073 |
$28K |
| 64491 |
|
838 |
455 |
$26K |
| 80053 |
Comprehensive metabolic panel |
7,746 |
6,275 |
$26K |
| 64634 |
|
518 |
356 |
$25K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
7,794 |
6,336 |
$24K |
| 84439 |
|
7,738 |
6,305 |
$23K |
| 20610 |
|
1,387 |
961 |
$22K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
8,621 |
6,243 |
$21K |
| 36415 |
Collection of venous blood by venipuncture |
8,434 |
6,855 |
$16K |
| 62323 |
|
218 |
174 |
$14K |
| 82670 |
|
1,199 |
983 |
$12K |
| 62370 |
|
716 |
534 |
$10K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
379 |
184 |
$10K |
| 84144 |
|
1,203 |
980 |
$9K |
| 83001 |
|
1,202 |
985 |
$8K |
| 83002 |
|
1,203 |
984 |
$8K |
| 82570 |
|
34,258 |
27,957 |
$6K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
128 |
107 |
$5K |
| J3490 |
Unclassified drugs |
169 |
70 |
$5K |
| 95991 |
|
182 |
151 |
$5K |
| 76942 |
|
597 |
402 |
$5K |
| 83986 |
|
34,271 |
27,958 |
$4K |
| 64495 |
|
274 |
141 |
$4K |
| 84403 |
|
709 |
541 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
208 |
157 |
$4K |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
582 |
482 |
$3K |
| J1020 |
Injection, methylprednisolone acetate, 20 mg |
1,795 |
1,411 |
$3K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
374 |
180 |
$3K |
| 64492 |
|
171 |
105 |
$3K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
563 |
457 |
$3K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
723 |
543 |
$2K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
241 |
108 |
$1K |
| 99205 |
Prolong outpt/office vis |
33 |
28 |
$1K |
| 64450 |
|
37 |
13 |
$1K |
| 99441 |
|
78 |
67 |
$1K |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
538 |
412 |
$1K |
| 62369 |
|
49 |
31 |
$572.93 |
| 93041 |
|
186 |
84 |
$460.47 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,098 |
1,394 |
$426.79 |
| 73564 |
|
14 |
13 |
$306.66 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
101 |
60 |
$275.46 |
| 72100 |
|
13 |
13 |
$244.50 |
| 81001 |
|
828 |
648 |
$149.17 |
| 81003 |
|
552 |
440 |
$116.22 |
| 99484 |
|
36 |
28 |
$115.78 |
| 94761 |
|
268 |
126 |
$95.65 |
| 99416 |
Prolong outpt/office vis |
31 |
13 |
$66.16 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
3,517 |
2,823 |
$36.86 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
398 |
199 |
$24.98 |
| J7050 |
Infusion, normal saline solution, 250 cc |
365 |
182 |
$23.13 |
| 99415 |
Prolong outpt/office vis |
31 |
13 |
$3.70 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
2,395 |
2,153 |
$0.00 |
| 99072 |
|
8,808 |
6,727 |
$0.00 |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
19 |
12 |
$0.00 |
| 99070 |
|
86 |
41 |
$0.00 |
| 80050 |
General health panel |
60 |
51 |
$0.00 |